Sam Brusco, Associate Editor02.28.24
Hanger, a provider of orthotic and prosthetic (O&P) patient care services and solutions, has launched Hanger Ventures.
Hanger Ventures is a subsidiary designed to focus on boosting innovation, developing technology, and improving patient outcomes. It will invest in entrepreneurs and small businesses with the aim of bringing innovative O&P solutions to the market.
Hanger’s chief clinical officer James Campbell, Ph.D., who heads the Hanger Institute and clinical and scientific affairs division, will also be the president of Hanger Ventures. He has 40 years of experience in the O&P profession with distinction in leadership and research.
Dr. Campbell also holds five issued U.S. patents as an inventor.
“Hanger Ventures will enable us to provide resources typically not accessible to entrepreneurs and small businesses, collaborating from incubation to commercialization,” said Hanger CEO Pete Stoy. “This type of collaboration enables us to be at the forefront of innovation, with involvement in research and development centered around patient outcomes, ultimately providing more access and better care across the O&P community.”
“Only at Hanger are we positioned to collaborate in this capacity,” added Dr. Campbell. “Hanger Ventures marks another significant step in our desire to transform O&P while creating value for our partners throughout the care continuum.”
Hanger Ventures is a subsidiary designed to focus on boosting innovation, developing technology, and improving patient outcomes. It will invest in entrepreneurs and small businesses with the aim of bringing innovative O&P solutions to the market.
Hanger’s chief clinical officer James Campbell, Ph.D., who heads the Hanger Institute and clinical and scientific affairs division, will also be the president of Hanger Ventures. He has 40 years of experience in the O&P profession with distinction in leadership and research.
Dr. Campbell also holds five issued U.S. patents as an inventor.
“Hanger Ventures will enable us to provide resources typically not accessible to entrepreneurs and small businesses, collaborating from incubation to commercialization,” said Hanger CEO Pete Stoy. “This type of collaboration enables us to be at the forefront of innovation, with involvement in research and development centered around patient outcomes, ultimately providing more access and better care across the O&P community.”
“Only at Hanger are we positioned to collaborate in this capacity,” added Dr. Campbell. “Hanger Ventures marks another significant step in our desire to transform O&P while creating value for our partners throughout the care continuum.”